According to differential expression, survival, and correlation analyses, AC008555.6, AC026356.1, TRHDE-AS1, and SNHG14 were predicted to be the upstream lncRNAs of the hsa-miR-340-5p/PLAUR axis with the most potential in NSCLC. This evidence concerns the gene PLAUR and non-small cell lung carcinoma.